CD14 and breast cancer: In the context of gut permeability and dysbiosis, the downregulation of genes in the BC-treated Ztm male group versus the Ztm male control group, especially Cd14, Dusp6, and Nfkbiz, suggests that BC treatment may have an impact on attenuating the inflammatory response.